DIABETIC RETINOPATHY
Clinical trials for DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Easier injections for blinding eye diseases? new syringe study begins
Disease control Not yet recruitingThis study tests whether a new prefilled syringe for the drug SCD411 (a proposed biosimilar to Eylea) is easy and safe for eye doctors to use. About 33 doctors will use the syringe to treat patients with wet age-related macular degeneration, retinal vein occlusion, diabetic macul…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Sam Chun Dang Pharm. Co. Ltd. • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
New eye drug trial aims to tame diabetes vision loss
Disease control Not yet recruitingThis early-stage study tests a new medicine (RO7663498) given as an eye injection to 30 adults with diabetic retinopathy, a diabetes complication that can damage vision. The main goal is to check safety and how the drug moves in the body, not to cure the condition. Participants m…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
One-Shot gene therapy aims to halt diabetic eye disease
Disease control Not yet recruitingThis study tests a single gene therapy injection (sura-vec) for people with diabetic retinopathy, a common diabetes complication that can damage the retina and cause vision loss. About 576 adults with moderate-to-severe non-proliferative diabetic retinopathy will receive either t…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New eye drops aim to slow diabetic retinopathy in small early trial
Disease control Not yet recruitingThis early-phase trial tests whether NPDR-01 eye drops can reduce tiny blood vessel bulges (microaneurysms) in the retina of people with non-proliferative diabetic retinopathy, a common complication of diabetes. Ten adults aged 18-75 with type 1 or type 2 diabetes will receive th…
Matched conditions: DIABETIC RETINOPATHY
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
AI eye check in your Doctor's office could save sight for thousands with diabetes
Diagnosis Not yet recruitingThis study tests whether using artificial intelligence to screen for diabetic eye disease during regular primary care visits helps more people get the follow-up eye care they need. About 4,000 adults with diabetes who haven't had an eye exam in the past year will take part. The g…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated May 26, 2026 07:00 UTC
-
New eye scanner could spot hidden clues in common vision disorders
Knowledge-focused Not yet recruitingThis study will test a new wide field OCTA device in 200 adults with various eye diseases like age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device provides better images of blood vessels in the back and front of the eye compared …
Matched conditions: DIABETIC RETINOPATHY
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Can eye scans and herbal medicine prevent diabetes brain damage?
Knowledge-focused Not yet recruitingThis study explores whether advanced eye and brain imaging can help diagnose and treat nerve and blood vessel damage caused by diabetes. Researchers will test a Chinese herbal medicine called Tangshen'an Granule in 160 adults aged 18-70 with diabetes. The goal is to see if the im…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Hejiang Ye • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
New eye scanners put to the test in pilot study
Knowledge-focused Not yet recruitingThis study tests two new eye imaging devices (R1 and HighRes OCT) against a standard device (SPECTRALIS) to see which gives clearer pictures of the retina. About 97 adults with healthy eyes or eye diseases like macular degeneration or diabetic retinopathy will take part. The goal…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Heidelberg Engineering GmbH • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC